Women with inflammatory bowel disease (IBD) often experience changes in gastrointestinal
symptoms during the menstrual cycle. Little is known about the mutual influences between
the menstrual function and gastrointestinal symptoms. We present the case of a girl
affected by IBD who experienced a close relationship between gastrointestinal symptoms
and disabling dysmenorrhea. The girl was diagnosed with pancolic UC at 12 years of
age. Since onset, menses became painful and irregular and seemed to trigger relapses
of abdominal pain, urgency and diarrhea. Gynaecological evaluations suggested numerous
estro-progestinic treatments (transdermal norelgestromine and ethinyl estradiol; vaginal
progesterone) but dysmenorrhea associated with diarrhea and urgency persisted. She
had several courses of steroids, optimization of rectal steroids and mesalazine, and
treatment escalation with mesalazine, azathioprine and infliximab with poor symptom
control. Finally transdermal gestodene and ethinyl estradiol were prescribed continuously
(suppressing menses) achieving symptom resolution and stable remission for 7 months.
Unfortunately the latter treatment was withdrawn from the market and had to be suspended;
the patient started to feel unwell again with menses. It is likely that she also suffers
from a degree of irritable bowel syndrome (IBS). The relationship between IBD, IBS
and menstrual cycle is complex; often one aspect may mimic, mask, worsen or activate
another and it is often difficult to differentiate which component is truly responsible
of the clinical picture. A better understanding of the relationship between hormonal
fluctuations due to the menstrual cycle and gastrointestinal symptoms in young women
with IBD is crucial for an appropriate management of disease.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Digestive and Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.